Drugs / Mammaglobin-A DNA Vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02204098 | Jan 2015 → Apr 2022 overdue | breast carcinoma | Washington University School of Medicine | Active not recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Mammaglobin-A DNA Vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02204098 ↗ |
| Modality | Vaccine | “Mammaglobin-A DNA Vaccine” NCT02204098 ↗ |